Abstract:Parathyroid hormone (PTH) receptor (PTHR) is a medically important family B G Protein Coupled Receptor (GPCR) that primarily couples to Gs/cAMP and Gq/Ca2+ signaling pathways and has a central role in regulating Ca2+ homeostasis and bone turnover. PTHR is activated by two endogenous hormones, endocrine PTH and paracrine PTH related protein (PTHrP), but only PTH mediates prolonged activation of the receptor and sustained cAMP responses after receptor internalization to the endosomes. To investigate the structural basis of prolonged activation of PTHR, we employed cryo‐EM and solved the high resolution (3Å) structure of PTHR coupled to Gs and activated by long‐acting PTH (LA‐PTH), an analog of PTH that remarkably sustains endosomal PTHR signaling and induces significantly prolonged elevation in blood calcium in mice and monkeys. LA‐PTH binds the receptor as a single extended α‐helix with its N‐terminus inserted deep into the transmembrane domain (TMD) of the receptor, while positioning the extracellular domain (ECD) of PTHR perpendicular to the cell membrane. The receptor activating N‐terminal half of LA‐PTH forms a dense network of hydrophobic and polar interactions with receptor's TMD resulting in a tight binding and giving structural basis for remarkably sustained activation of PTHR by LA‐PTH. Binding of LA‐PTH activates the receptor by inducing partial unwinding of the C‐terminus of transmembrane helix 6 (TM6) and a sharp kink at the middle of this helix, a hallmark of family B GPCR activation. This results in a pronounced outward movement of TM6, opening the cytosolic cavity of the receptor, which allows subsequent G protein coupling. Additionally, our cryo‐EM data revealed structural dynamics of PTHR demonstrated by the ability of receptor ECD to adopt multiple conformational states. Together, these results reveal the structural determinants of PTHR signaling and provide a molecular framework for structure‐based design of novel therapeutics for osteoporosis and hypocalcaemia treatment.Support or Funding InformationNIH R01 DK116780, DK102495 and DK111427 awarded to JPV; the Jay and Betty Van Andel Foundation and NIH GM127710 grants awarded to EXThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

The Notch pathway regulates the bone gain induced by PTH anabolic signaling

Regulation and function of notch ligands in macrophages

Notch Signaling in Osteocytes Differentially Regulates Cancellous and Cortical Bone Remodeling

Anabolic actions of Notch on mature bone

Notch Signaling Maintains Bone Marrow Mesenchymal Progenitors by Suppressing Osteoblast Differentiation

NOTCH1 Regulates Osteoclastogenesis Directly in Osteoclast Precursors and Indirectly Via Osteoblast Lineage Cells*

Notch in skeletal physiology and disease

Notch expressed by osteocytes plays a critical role in mineralisation

Notch Signaling and the Skeleton

Dimorphic effects of Notch signaling in bone homeostasis

PTH induces modification of transductive events in otosclerotic bone cell cultures

Transcriptional Regulation of Bmp2 Expression by the Pth-Creb Signaling Pathway in Osteoblasts

Inhibition of Phosphodiesterase 5 Reduces Bone Mass by Suppression of Canonical Wnt Signaling

Suppression of Notch Signaling in Osteoclasts Improves Bone Regeneration and Healing

Calcium Sensing Receptor Function Supports Osteoblast Survival and Acts as a Co-Factor in PTH Anabolic Actions in Bone.

Notch Signaling in Osteogenesis, Osteoclastogenesis, and Angiogenesis

Structural Basis of Activation and Sustained Signaling by the PTH Receptor

Induction of osteogenesis by bone-targeted Notch activation

NOTCHing the bone: Insights into multi-functionality

PTH and the Regulation of Mesenchymal Cells within the Bone Marrow Niche